Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MOBILE trial of prolonged-release fampridine in multiple sclerosis
2012-000368-90Phase 2Completed
- Sponsor
- Biogen
- Start
- Jun 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in multiple sclerosis (MS) comparing Fampridine with Placebo (2 arms). Started Jun 2012; status: completed.
02
Drugs
dalfampridine
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on 2012-000368-90.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-000368-90.